-
1
-
-
19244366336
-
Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrosis and hypersensitivity syndrome
-
Ghislain PD Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrosis and hypersensitivity syndrome. Dermatol Online J 2002 8 : 5.
-
(2002)
Dermatol Online J
, vol.8
, pp. 5
-
-
Ghislain, P.D.1
Roujeau, J.C.2
-
2
-
-
9844244022
-
Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome
-
Descamps V Bouscarat F Laglenne S et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997 137 : 605 8.
-
(1997)
Br J Dermatol
, vol.137
, pp. 605-8
-
-
Descamps, V.1
Bouscarat, F.2
Laglenne, S.3
-
3
-
-
0031707391
-
Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome
-
Suzuki Y Inagi R Aono T Yamanishi K Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998 134 : 1108 12.
-
(1998)
Arch Dermatol
, vol.134
, pp. 1108-12
-
-
Suzuki, Y.1
Inagi, R.2
Aono, T.3
Yamanishi, K.4
Shiohara, T.5
-
4
-
-
0035075775
-
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms
-
Descamps V Valance A Edlinger C et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001 137 : 301 4.
-
(2001)
Arch Dermatol
, vol.137
, pp. 301-4
-
-
Descamps, V.1
Valance, A.2
Edlinger, C.3
-
5
-
-
10544231458
-
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entitities
-
Callot V Roujean JC Bagot M et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entitities. Arch Dermatol 1996 132 : 1315 21.
-
(1996)
Arch Dermatol
, vol.132
, pp. 1315-21
-
-
Callot, V.1
Roujean, J.C.2
Bagot, M.3
-
6
-
-
0030733256
-
Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction
-
Higa K Hirata K Dan K. Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction. Pain 1997 73 : 97 9.
-
(1997)
Pain
, vol.73
, pp. 97-9
-
-
Higa, K.1
Hirata, K.2
Dan, K.3
-
7
-
-
6344277192
-
A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome
-
Seino Y Yamauchi M Hirai C et al. A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome. Diabet Med 2004 21 : 1156 7.
-
(2004)
Diabet Med
, vol.21
, pp. 1156-7
-
-
Seino, Y.1
Yamauchi, M.2
Hirai, C.3
-
8
-
-
0026002778
-
Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN)
-
Sakellariou G Koukoudis P Karpouzas J et al. Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN). Int J Artif Organs 1991 14 : 634 8.
-
(1991)
Int J Artif Organs
, vol.14
, pp. 634-8
-
-
Sakellariou, G.1
Koukoudis, P.2
Karpouzas, J.3
-
10
-
-
0031862794
-
A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis
-
Yamada H Takamori K Yaguchi H Ogawa H. A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis. Ther Apher 1998 2 : 153 6.
-
(1998)
Ther Apher
, vol.2
, pp. 153-6
-
-
Yamada, H.1
Takamori, K.2
Yaguchi, H.3
Ogawa, H.4
-
11
-
-
33745384697
-
Molecular Mechanism of T cell-mediated cytotoxity
-
In: Sitkovsky, M.V. Henkart, P.A., eds. Philadelphia, PA: Lippincott Williams & Wilkins Press
-
Golstein P. Molecular Mechanism of T cell-mediated cytotoxity. In: Sitkovsky MV Henkart PA, eds. Cytotoxic Cells. Philadelphia, PA : Lippincott Williams & Wilkins Press, 2000 1 15.
-
(2000)
Cytotoxic Cells.
, pp. 1-15
-
-
Golstein, P.1
-
12
-
-
0036152644
-
Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity
-
Posadas SJ Padial A Torres MJ et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002 109 : 155 61.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 155-61
-
-
Posadas, S.J.1
Padial, A.2
Torres, M.J.3
|